Results 161 to 170 of about 4,477 (231)

Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery. [PDF]

Int J Med Sci
Lou Y, Ma W, Jiang F, Guan J.
europepmc   +1 more source

Accurate prediction of benign and malignant adnexal tumors in surgical resection and conservative treatment: construction and external validation of a diagnostic model based on CEUS, HE4, and O-RADS US v2022 evaluation. [PDF]

J Ovarian Res
Liu C, Zhu Y, Dai K, Tan B, Dong H, Lin J, He R, Lu M, Li Y.   +8 more
europepmc   +1 more source

Neoadjuvant hyperthermic intraperitoneal chemotherapy: impact on chemotherapy response score and prognosis in high-grade serous ovarian carcinoma. [PDF]

Front Oncol
Feng X, Wang Y, Li H, Zhang Y, Li L, Ma Y, Wang S, Wang L.   +7 more
europepmc   +1 more source

Enhanced efficacy and safety of combining Aidi injection with megestrol acetate for endometrial cancer treatment. [PDF]

Am J Transl Res
Li Q, Li J, Zhang C.
europepmc   +1 more source

A rare large cell variant of small-cell carcinoma of the ovary, hypercalcemic type in a postmenopausal woman: Case report. [PDF]

Medicine (Baltimore)
Liu S, Che S, Jin C, Deng Y, Zhao D.
europepmc   +1 more source

Early Detection and Prevention of Ovarian Cancer. [PDF]

Cancers (Basel)
Montemorano L, Huffman L, Barroilhet L.
europepmc   +1 more source

Effects of nedaplatin combined with paclitaxel liposomes or docetaxel on survival rate and biomarkers in patients with recurrent ovarian cancer. [PDF]

Am J Transl Res
Deng J, Cai Y, Liao J, Hou R, Cui J.
europepmc   +1 more source

Human Epididymis Protein 4 in Transcatheter Aortic Valve Implantation: Diagnostic and Prognostic Value. [PDF]

JACC Adv
Giuliani C, Zanuttini A, Nuche J, Farjat Pasos JI, Bernard J, Lionel T, Jacob S, Abu-Alhayja'a R, Beaudoin J, Côté N, DeLarochellière R, Paradis JM, Clavel MA, Arsenault BJ, Rodés-Cabau J, Pibarot P, Hecht S.   +16 more
europepmc   +1 more source

A new risk algorithm combining D-dimer and HE4 differentiates borderline tumor from patients with ovarian tumor. [PDF]

Transl Cancer Res
Zhang M, Zhang Y, Liu G, Ge L.
europepmc   +1 more source

Impacts of BRCA mutations and clinical factors on niraparib efficacy in patients with platinum-sensitive recurrent ovarian cancer: a retrospective study. [PDF]

Am J Cancer Res
Hu Z, Li L, Yang Z, Liu Y, Dong L, Li F.
europepmc   +1 more source